Skip to main content
Top
Published in: Endocrine 3/2007

01-06-2007 | Original Paper

Evolving hypopituitarism as a consequence of traumatic brain injury (TBI) in childhood—call for attention

Authors: Milica Medic-Stojanoska, Sandra Pekic, Nikola Curic, Dragana Djilas-Ivanovic, Vera Popovic

Published in: Endocrine | Issue 3/2007

Login to get access

Abstract

Hypopituitarism is a common complication of TBI in long-term survivors, more frequent than previously realized. It may be partial or complete, sometimes very subtle without visible lesions in hypothalamo-pituitary region and is diagnosed only by biochemical means. Neuroendocrine abnormalities caused by TBI may have significant implications for the recovery and rehabilitation of these patients. The subjects at risk are those who have suffered moderate to severe trauma, although mild intensity trauma may precede hypopituitarism also. Particular attention should be paid to this problem in children and adolescents. We describe a patient with hypopituitarism thought to be idiopathic due to mild head trauma which caused diabetes insipidus in childhood, gradual failure of pituitary hormones during the period of growth and development, and metabolic (dyslipidemia), physical (obesity), and cognitive impairments in the adult period.
Literature
1.
go back to reference D. Kelly, I. Gonzalo, P. Cohan, N. Berman, R. Swerdloff, C. Wang, J. Neurosurg. 93, 743–752 (2000)PubMed D. Kelly, I. Gonzalo, P. Cohan, N. Berman, R. Swerdloff, C. Wang, J. Neurosurg. 93, 743–752 (2000)PubMed
2.
go back to reference S. Benvenga, A. Campenni, R.M. Ruggeri, F. Trimarrchi, J. Clin. Endocrinol. Metabol. 85, 1353–1361 (2000)CrossRef S. Benvenga, A. Campenni, R.M. Ruggeri, F. Trimarrchi, J. Clin. Endocrinol. Metabol. 85, 1353–1361 (2000)CrossRef
3.
go back to reference S.A. Lieberman, A.L. Oberoi, C.R. Gilkinson, B.E. Masel, R.J. Urban, J. Clin. Endocrinol. Metabol. 86, 2752–2756 (2001)CrossRef S.A. Lieberman, A.L. Oberoi, C.R. Gilkinson, B.E. Masel, R.J. Urban, J. Clin. Endocrinol. Metabol. 86, 2752–2756 (2001)CrossRef
4.
go back to reference G. Aimaretti, M.R. Ambrosio, C. Di Somma, A. Fusco, S. Cannavo, M. Gasperi, C. Scaroni, L. De Marinis, S. Benvenga, E.C.D. Uberti, G. Lombardi, F. Mantero, E. Martino, G. Giordano, E. Ghigo, Clin. Endocrinol. 61, 320–326 (2004)CrossRef G. Aimaretti, M.R. Ambrosio, C. Di Somma, A. Fusco, S. Cannavo, M. Gasperi, C. Scaroni, L. De Marinis, S. Benvenga, E.C.D. Uberti, G. Lombardi, F. Mantero, E. Martino, G. Giordano, E. Ghigo, Clin. Endocrinol. 61, 320–326 (2004)CrossRef
5.
go back to reference M.D.E. Bondanelli, L. Marinis, M.R. Ambrosio, M. Monesi, D. Valle, M.C. Zatelli, A. Fusco, A. Bianchi, M. Farneti, E.C. degli Uberti, J. Neurotrauma 21, 685–696 (2004)PubMedCrossRef M.D.E. Bondanelli, L. Marinis, M.R. Ambrosio, M. Monesi, D. Valle, M.C. Zatelli, A. Fusco, A. Bianchi, M. Farneti, E.C. degli Uberti, J. Neurotrauma 21, 685–696 (2004)PubMedCrossRef
6.
go back to reference V. Popovic, S. Pekic, D. Pavlovic, N. Maric, M. Jasovic-Gasic, B. Djurovic, M. Medic-Stojanoska, V. Zivkovic, M. Stojanovic, M. Doknic, N. Milic, M. Djurovic, C. Dieguez, F.F. Casanueva, J. Endocrinol. Invest. 27, 1048–1054 (2004)PubMed V. Popovic, S. Pekic, D. Pavlovic, N. Maric, M. Jasovic-Gasic, B. Djurovic, M. Medic-Stojanoska, V. Zivkovic, M. Stojanovic, M. Doknic, N. Milic, M. Djurovic, C. Dieguez, F.F. Casanueva, J. Endocrinol. Invest. 27, 1048–1054 (2004)PubMed
7.
go back to reference A. Leal-Cerro, J.M. Flores, M. Rincon, F. Murillo, M. Pujol, F. Garcia-Pesquera, C. Dieguez, F.F. Casanueva, Clin. Endocrinol. 62, 525–532 (2005)CrossRef A. Leal-Cerro, J.M. Flores, M. Rincon, F. Murillo, M. Pujol, F. Garcia-Pesquera, C. Dieguez, F.F. Casanueva, Clin. Endocrinol. 62, 525–532 (2005)CrossRef
8.
go back to reference A. Agha, B. Rogers, D. Mylotte, F. Taleb, W. Tormey, J. Philips, C. Thompson, Clin. Endocrinol. 60, 584–591 (2004)CrossRef A. Agha, B. Rogers, D. Mylotte, F. Taleb, W. Tormey, J. Philips, C. Thompson, Clin. Endocrinol. 60, 584–591 (2004)CrossRef
9.
go back to reference F. Tanriverdi, H. Senyurek, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, F. Kelestimur, J. Clin. Endocrinol. Metabol. 91, 2105–2111 (2006)CrossRef F. Tanriverdi, H. Senyurek, K. Unluhizarci, A. Selcuklu, F.F. Casanueva, F. Kelestimur, J. Clin. Endocrinol. Metabol. 91, 2105–2111 (2006)CrossRef
10.
go back to reference S. Benvenga, T. Vigo, R. Ruggeri, D. Lapa, B. Almoto, F. LoDuidice, M. Longo, A. Blandino, A. Campenni, S. Cannavo, F. Trimarchi, Am. J. Med. 116, 767–771 (2004)PubMedCrossRef S. Benvenga, T. Vigo, R. Ruggeri, D. Lapa, B. Almoto, F. LoDuidice, M. Longo, A. Blandino, A. Campenni, S. Cannavo, F. Trimarchi, Am. J. Med. 116, 767–771 (2004)PubMedCrossRef
11.
go back to reference Growth Hormone Research Society: consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency, J. Clin. Endocrinol. Metabol. 83, 379–381 (1998)CrossRef Growth Hormone Research Society: consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency, J. Clin. Endocrinol. Metabol. 83, 379–381 (1998)CrossRef
12.
go back to reference Growth Hormone Research Society Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society, J. Clin. Endocrinol. Metabol. 86, 1868–1870 (2001)CrossRef Growth Hormone Research Society Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society, J. Clin. Endocrinol. Metabol. 86, 1868–1870 (2001)CrossRef
13.
go back to reference G. Aimaretti, B. Bellone, L. Di Vito, G. Corneli, E. Arvat, I. Benso, F. Camanni, E. Ghigo, J. Clin. Endocrinol. Metabol. 85, 3693–3699 (2000)CrossRef G. Aimaretti, B. Bellone, L. Di Vito, G. Corneli, E. Arvat, I. Benso, F. Camanni, E. Ghigo, J. Clin. Endocrinol. Metabol. 85, 3693–3699 (2000)CrossRef
14.
go back to reference F. Kelestimur, V. Popovic, A. Leal, P.S. Van Dam, E. Torrens, L.F. Perez Mendez, Y. Greenman, P.F.H. Koppeschaar, C. Dieguez, F.F. Casanueva, Clin. Endocrinol. 64, 667–671 (2006)CrossRef F. Kelestimur, V. Popovic, A. Leal, P.S. Van Dam, E. Torrens, L.F. Perez Mendez, Y. Greenman, P.F.H. Koppeschaar, C. Dieguez, F.F. Casanueva, Clin. Endocrinol. 64, 667–671 (2006)CrossRef
15.
go back to reference E. Ghigo, H.G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, F. Cammani, Eur. J. Endocrinol. 134, 352–356 (1996)PubMedCrossRef E. Ghigo, H.G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, F. Cammani, Eur. J. Endocrinol. 134, 352–356 (1996)PubMedCrossRef
16.
go back to reference V. Popovic, A. Leal, D. Micic, H.P.F. Kooppeschaar, E. Torrens, C. Paramo, S. Obradovic, C. Dieguez, F.F. Casanueva, Lancet 356(9236), 1137–1142 (2000)PubMedCrossRef V. Popovic, A. Leal, D. Micic, H.P.F. Kooppeschaar, E. Torrens, C. Paramo, S. Obradovic, C. Dieguez, F.F. Casanueva, Lancet 356(9236), 1137–1142 (2000)PubMedCrossRef
18.
go back to reference V. Popovic, S. Pekic, M. Doknic, D. Micic, S. Damjanovic, M. Zarkovic, G. Aimaretti, G. Corneli, E. Ghigo, C. Dieguez, F.F. Casanueva, Clin. Endocrinol.0 59, 251–257 (2003)CrossRef V. Popovic, S. Pekic, M. Doknic, D. Micic, S. Damjanovic, M. Zarkovic, G. Aimaretti, G. Corneli, E. Ghigo, C. Dieguez, F.F. Casanueva, Clin. Endocrinol.0 59, 251–257 (2003)CrossRef
20.
go back to reference J. Cain, G. Williams, R. Dluhy, Can. Med. Assoc. J. 107, 617–622 (1972)PubMed J. Cain, G. Williams, R. Dluhy, Can. Med. Assoc. J. 107, 617–622 (1972)PubMed
21.
go back to reference D. Hoffman, A. O’Sullivan, R. Baxter, K. Ho, Lancet 343, 1065–1068 (1994) D. Hoffman, A. O’Sullivan, R. Baxter, K. Ho, Lancet 343, 1065–1068 (1994)
22.
Metadata
Title
Evolving hypopituitarism as a consequence of traumatic brain injury (TBI) in childhood—call for attention
Authors
Milica Medic-Stojanoska
Sandra Pekic
Nikola Curic
Dragana Djilas-Ivanovic
Vera Popovic
Publication date
01-06-2007
Publisher
Humana Press Inc
Published in
Endocrine / Issue 3/2007
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-007-0037-4

Other articles of this Issue 3/2007

Endocrine 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine